Table 2. Blood Routine Index, According to Peritoneal Metastasis Involvement.
Factors | Total | PMPG | PMNG | P |
---|---|---|---|---|
WBC count | 6.00 (4.99–7.20) | 6.00 (5.05–7.30) | 6.00 (4.96–7.16) | 0.735 |
Neutrophil count | 3.70 (2.90–4.60) | 3.80 (3.15–4.75) | 3.70 (2.90–4.60) | 0.151 |
Lymphocyte count | 1.60 (1.30–2.00) | 1.50 (1.20–1.90) | 1.60 (1.30–2.00) | 0.034 * |
Platelet count | 221.00 (179.00–267.00) | 227.00 (185.00–307.50) | 221.00 (178.00–263.00) | 0.035 * |
Monocyte count | 0.40 (0.30–0.50) | 0.40 (0.30–0.50) | 0.40 (0.30–0.50) | 0.144 |
NLR | 2.24 (1.64–3.07) | 2.45 (1.86–3.35) | 2.20 (1.60–3.06) | 0.011 * |
PLR | 132.25 (99.14–180.47) | 152.78 (118.74–207.56) | 130 (98.00–177.27) | 0.001 * |
MLR | 0.285 (0.18–0.35) | 0.29 (0.18–0.35) | 0.27 (0.16–0.36) | 0.642 |
* Statistically significant (P < 0.05).
The values of the variables are presented as the median (IQR). IQR, interquartile range; MLR, monocyte-to-lymphocyte ratio; NLR, neutrophil-to-lymphocyte ratio; PLR, platelet-to-lymphocyte ratio; WBC, white blood cell; PMPG, peritoneal metastasis positive group. PMNG, peritoneal metastasis negative group